Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia
Titel:
Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia
Auteur:
Gómez García, Lara Maria Escudero, Adela Mestre, Carmen Fuster Soler, Jose L. Martínez, Antonia Pascual Vagace Valero, Jose M. Vela, María Ruz, Beatriz Navarro, Alfonso Fernández, Lucia Fernández, Adrián Leivas, Alejandra Martínez-López, Joaquin Ferreras, Cristina De Paz, Raquel Blanquer, Miguel Galán, Victor González, Berta Corral, Dolores Sisinni, Luisa Mirones, Isabel Balas, Antonio Vicario, José Luis Valle, Paula Borobia, Alberto M. Pérez-Martínez, Antonio